Evidence map›Paper›PMID 41190070›Full record

ArticleFrontiers in immunology2025

Case Report: Fatal disseminated cytomegalovirus infection following cyclophosphamide therapy in a young patient with systemic lupus erythematosus.

Mohanad Jaber, Loai Muhtasib, Hebatallah Qawasmeh, Mariam Thalji, Hiba Y Yaghmour, Hasan Hroob, Ashraf Al-Zughayyar, Majed Dweik

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mohanad JaberFaculty of Medicine, Palestine Polytechnic University, Hebron, Palestine.
Loai MuhtasibFaculty of Medicine, Palestine Polytechnic University, Hebron, Palestine.
Hebatallah QawasmehFaculty of Medicine, Palestine Polytechnic University, Hebron, Palestine.
Mariam ThaljiFaculty of Medicine, Palestine Polytechnic University, Hebron, Palestine.
Hiba Y YaghmourFaculty of Medicine, Palestine Polytechnic University, Hebron, Palestine.
Hasan HroobMedical Intensive Care Unit, Al-Ahli Hospital, Hebron, Palestine.
Ashraf Al-ZughayyarFaculty of Medicine, Palestine Polytechnic University, Hebron, Palestine.
Majed DweikFaculty of Medicine, Palestine Polytechnic University, Hebron, Palestine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibody production and systemic inflammation. Immunosuppressive treatment is often required to achieve remission. While opportunistic infection rates have risen in this patient population, cytomegalovirus is one of the most lethal opportunistic infections with fatal consequences. Herein, we report a case of an 18-year-old female patient with a two-year history of SLE complicated by lupus nephritis who presented with gastrointestinal symptoms while on immunosuppressive medication. She then developed a cascade of serious complications, including colitis, fulminant liver failure, acute pancreatitis, and pneumonitis, which progressed to disseminated intravascular coagulation (DIC). Detailed investigations were conducted, and the patient was diagnosed with disseminated cytomegalovirus infection. Multidisciplinary supportive management failed to save her life. Disseminated CMV infection is a rare but deadly condition in patients with SLE. This case emphasizes the importance of maintaining a high level of suspicion and considering CMV infection as a differential diagnosis in patients with SLE on immunosuppressive therapy who have obvious gastrointestinal symptoms. This allows for early detection, timely management, and administration of antiviral drugs, leading to improved overall patient health outcomes.

Indexed as

CyclophosphamideCytomegalovirusCytomegalovirus InfectionsImmunosuppressive AgentsLupus Erythematosus, SystemicOpportunistic InfectionsAdolescentFatal OutcomeFemaleHumansCyclophosphamideImmunosuppressive Agentscase reportcolitiscytomegalovirus (CMV)DICrheumatologysepsissystemic lupus erythematosus (SLE)

Identifiers

PMID41190070
PMCPMC12580208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.